Related Experiment Videos
Cardiac infections in the immunocompromised host
Cardiology Clinics
|November 1, 1984
Summary
Bacterial and fungal heart infections are increasing in compromised patients, often linked to other health issues or treatments. Early diagnosis and aggressive treatment are crucial for improving survival rates in these uncommon cardiac conditions.
Area of Science:
- Cardiology
- Infectious Diseases
- Pathology
Background:
- Cardiac infections, though uncommon, are rising in compromised patients.
- Risk factors include pre-existing infections, neoplasms, cardiac surgery, and substance abuse.
Purpose of the Study:
- To review the epidemiology, causative organisms, and clinical features of bacterial and fungal heart infections.
- To highlight diagnostic challenges and emphasize the importance of early detection and treatment.
Main Methods:
- Review of existing literature on bacterial and fungal endocarditis, myocarditis, and pericarditis.
- Analysis of causative pathogens, common sites of infection, and patient demographics.
Main Results:
- Staphylococcus aureus is now the most common bacterial cause, unlike the historical Streptococcus prevalence.
- Gram-negative bacilli are significant contributors; endocardium and left-sided valves (mitral) are most frequently affected.
- Fungal infections, often Candida or Aspergillus, are increasing, particularly in immunocompromised patients or those post-surgery.
- Disseminated fungal infections commonly involve lungs, kidneys, and brain.
- Diagnosis can be challenging, with blood cultures positive in only about two-thirds of bacterial and one-third of fungal cases.
Conclusions:
- Bacterial and fungal heart infections require prompt diagnosis and aggressive management.
- Early identification through methods like precipitin tests and antibody titers can improve patient outcomes.
- Increased vigilance is needed for these rising cardiac infections in vulnerable populations.